Job Recruitment Website - Zhaopincom - How about Jiaxing Lishan Minglang Biomedical Technology Co., Ltd.?
How about Jiaxing Lishan Minglang Biomedical Technology Co., Ltd.?
The unified social credit code/registration number of Jiaxing Lishan Minglang Biomedical Technology Co., Ltd. is 91330402146712828y, and the enterprise legal person is Lu. At present, the enterprise is in the state of opening.
The business scope of Jiaxing Lishan Minglang Biomedical Technology Co., Ltd. is: manufacturing and processing Class III 6822 medical optical instruments, instruments and endoscopic equipment. Production and sales of first-class medical devices (antipyretic stickers and ultrasonic coupling agents only), cosmetics and disinfection products; Biomedical research and development. In Zhejiang Province, the total registered capital of companies with similar business scope is1892.02 million yuan, and the main capital is concentrated in enterprises with scale of1000-50 million and 50 million, totaling 8 1. Within the scope of this province, the registered capital of mobile enterprises belongs to the general.
See more information and materials of Jiaxing Lishan Minglang Biomedical Technology Co., Ltd. through Baidu Enterprise Credit.
- Related articles
- After downloading enterprise WeChat, can you see the recruitment of nearby enterprises?
- Xiaodian district Summer Love Shop in Taiyuan, recruitment information, how about xiaodian district Summer Love Shop in Taiyuan?
- Li Yaoqing, the former chairman of Guangxi Liuzhou Bank, was investigated and was involved in a 42 billion loan fraud case.
- Behind the scenes of Private Zhang Ga.
- How about Shanghai Haier Washing Electric Co., Ltd.
- What's the telephone number of Wuhan Lansha Medical Inspection Co., Ltd.?
- What is the telephone number of Tongxu Anxin Human Resources Service Co., Ltd.?
- How about Yulin Delong Environmental Protection Technology Co., Ltd.?
- Inner Mongolia Baotou City Human Resources and Social Security Bureau official website
- Xuzhou University started in 2023.